Tenet Healthcare Co. (NYSE:THC) Shares Bought by Mariner LLC

Mariner LLC lifted its stake in shares of Tenet Healthcare Co. (NYSE:THC) by 24.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 8,604 shares of the company’s stock after buying an additional 1,697 shares during the quarter. Mariner LLC’s holdings in Tenet Healthcare were worth $1,086,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of THC. WR Wealth Planners LLC boosted its stake in shares of Tenet Healthcare by 2,836.4% in the fourth quarter. WR Wealth Planners LLC now owns 323 shares of the company’s stock valued at $41,000 after purchasing an additional 312 shares during the period. Smartleaf Asset Management LLC lifted its holdings in Tenet Healthcare by 30.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 471 shares of the company’s stock worth $59,000 after buying an additional 110 shares in the last quarter. Kestra Investment Management LLC purchased a new position in Tenet Healthcare in the 4th quarter valued at about $60,000. Wilmington Savings Fund Society FSB increased its position in shares of Tenet Healthcare by 1,352.8% during the fourth quarter. Wilmington Savings Fund Society FSB now owns 523 shares of the company’s stock worth $66,000 after acquiring an additional 487 shares during the last quarter. Finally, Spire Wealth Management lifted its stake in shares of Tenet Healthcare by 19.5% in the fourth quarter. Spire Wealth Management now owns 558 shares of the company’s stock worth $70,000 after acquiring an additional 91 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Insider Buying and Selling at Tenet Healthcare

In other news, Director J Robert Kerrey sold 9,525 shares of the business’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total value of $1,194,720.75. Following the sale, the director now owns 27,378 shares of the company’s stock, valued at approximately $3,434,022.54. The trade was a 25.81 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.81% of the stock is owned by corporate insiders.

Tenet Healthcare Price Performance

Shares of NYSE:THC opened at $121.99 on Friday. Tenet Healthcare Co. has a 52 week low of $92.01 and a 52 week high of $171.20. The firm has a market capitalization of $11.51 billion, a P/E ratio of 3.78, a PEG ratio of 1.02 and a beta of 1.77. The firm’s 50 day moving average is $126.50 and its two-hundred day moving average is $136.90. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. Analysts anticipate that Tenet Healthcare Co. will post 12.24 earnings per share for the current year.

Wall Street Analysts Forecast Growth

THC has been the topic of a number of recent analyst reports. Truist Financial cut their target price on Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. StockNews.com upgraded shares of Tenet Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, March 13th. Robert W. Baird reissued a “neutral” rating and issued a $137.00 target price (down previously from $153.00) on shares of Tenet Healthcare in a research report on Tuesday, April 15th. Barclays decreased their price target on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating for the company in a research note on Thursday, February 13th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $177.00 price objective on shares of Tenet Healthcare in a research note on Thursday, February 13th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $165.44.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.